Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2024Annals of Laboratory MedicineOpen Access

Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMarco Lincango YupankiVAVerónica AndreoliHRHernán Garcı́a Rivello

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yupanki et al. (2024) studied this question.

synapsesocial.com/papers/68e5ee87b6db643587582fcchttps://doi.org/10.3343/alm.2024.0089
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes2023 · 119 citations
  2. 2IPSS, IPSS-R and IPSS-M had no identical prognostic power depending on treatment in myelodysplastic syndromes2026
  3. 3Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification2024 · 7 citations
  4. 4Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes2024 · 6 citations
  5. 5Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.2024 · 1 citations